Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spannagl

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Thrombosis Research|September 28, 1999
Replacement of coagulation factors in liver or multiple organ dysfunctionM Spannagl, W Schramm
Der Anaesthesist|May 1, 1997
[Preoperative withdrawal of Marcumar]W Schramm, M Spannagl
MMW Fortschritte Der Medizin|September 11, 2009
[General practitioner's considerations if INR doesn't change]A Dick, M Spannagl
Der Internist|October 12, 2021
[Anticoagulation in patients with COVID-19]I Pekrul, M Spannagl, S Nitschmann
Der Anaesthesist|February 13, 2010
[Perioperative management of patients with coronary stents in non-cardiac surgery]J Jambor, M Spannagl, B Zwissler
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Phosphatidylethanolamine participates in the stimulation of the contact system of coagulation by very-low-density lipoproteinsS Klein, M Spannagl, B Engelmann
Der Anaesthesist|June 4, 2005
[High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion]B Heindl, C Delorenzo, M Spannagl
Der Anaesthesist|April 1, 2003
[Point-of-care testing of hemostatic alterations in anaesthesia and intensive care]A Calatzis, M Heesen, M Spannagl
Hamostaseologie|September 6, 2006
[Safety of plasma-derived factor concentrates: an example of pharmacovigilance with fibrinogen and factor XIII-concentrate]M Spannagl, Ch Joch, B Heindl
Der Internist|November 1, 1992
[Classification of findings and staging in hemostaseology]W Schramm, M Spannagl, M Iven
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Thrombosis Research|September 28, 1999
Replacement of coagulation factors in liver or multiple organ dysfunctionM Spannagl, W Schramm
Der Anaesthesist|May 1, 1997
[Preoperative withdrawal of Marcumar]W Schramm, M Spannagl
MMW Fortschritte Der Medizin|September 11, 2009
[General practitioner's considerations if INR doesn't change]A Dick, M Spannagl
Der Internist|October 12, 2021
[Anticoagulation in patients with COVID-19]I Pekrul, M Spannagl, S Nitschmann
Der Anaesthesist|February 13, 2010
[Perioperative management of patients with coronary stents in non-cardiac surgery]J Jambor, M Spannagl, B Zwissler
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Phosphatidylethanolamine participates in the stimulation of the contact system of coagulation by very-low-density lipoproteinsS Klein, M Spannagl, B Engelmann
Der Anaesthesist|June 4, 2005
[High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion]B Heindl, C Delorenzo, M Spannagl
Der Anaesthesist|April 1, 2003
[Point-of-care testing of hemostatic alterations in anaesthesia and intensive care]A Calatzis, M Heesen, M Spannagl
Hamostaseologie|September 6, 2006
[Safety of plasma-derived factor concentrates: an example of pharmacovigilance with fibrinogen and factor XIII-concentrate]M Spannagl, Ch Joch, B Heindl
Der Internist|November 1, 1992
[Classification of findings and staging in hemostaseology]W Schramm, M Spannagl, M Iven
Pageof 13